Epothilone in Recurrent Glioblastoma Patients
NCT00397072
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
15
Enrollment
OTHER
Sponsor class
Conditions
Glioblastoma
Interventions
DRUG:
ZK 219477
Sponsor
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta